Branchio-oculo-facial syndrome (BOFS) is a rare disorder characterized by maldevelopment of the first and second branchial arches, skin defects, facial dysmorphism, auricular, ophthalmological and oral abnormalities. A high clinical variability has been reported. Recently, mutations in TFAP2A were found to underlie this condition. A small duplication on 5q13 was detected in 2 family members with mild BOFS features. Molecular cytogenetic delineation of the duplication demonstrated that only 7 genes are affected: LOC100289045, RGNEF, UTP15, ANKRA2, FUNDC2P1, BTF3 and FOXD1. The latter is expressed in the developing branchial arches and involved in cranio-facial development. Zebrafish embryos with combined inhibition of the expression of foxd1l and tfap2a show optic axis defects. We identified a novel locus associated with a mild BOFS-like phenotype. The functional in vivo experiments suggest an interaction between FOXD1 and TFAP2A.

Keywords:
Branchial defects, Branchio-oculo-facial syndrome, FOXD1, TFAP2A, Zebrafish
1.
Bassett EA, Williams T, Zacharias AL, Gage PJ, Fuhrmann S, West-Mays JA: AP-2alpha knockout mice exhibit optic cup patterning defects and failure of optic stalk morphogenesis. Hum Mol Genet 19:1791–1804 (2010).
2.
Breslau-Siderius EJ, Wijnen JT, Dauwerse JG, de Pater JM, Beemer FA, Khan PM: Paternal duplication of chromosome 5q11.2–5q14 in a male born with craniostenosis, ear tags, kidney dysplasia and several other anomalies. Hum Genet 92:481–485 (1993).
3.
Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al: The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159–166 (2001).
4.
Gebbink MF, Kranenburg O, Poland M, van Horck FP, Houssa B, Moolenaar WH: Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. J Cell Biol 137:1603–1613 (1997).
5.
Gestri G, Osborne RJ, Wyatt AW, Gerrelli D, Gribble S, et al: Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators. Hum Genet 126:791–803 (2009).
6.
Herrera E, Marcus R, Li S, Williams SE, Erskine L, et al: Foxd1 is required for proper formation of the optic chiasm. Development 131:5727–5739 (2004).
7.
Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF: Stages of embryonic development of the zebrafish. Dev Dyn 203:253–310 (1995).
8.
Luo T, Lee YH, Saint-Jeannet JP, Sargent TD: Induction of neural crest in Xenopus by transcription factor AP2alpha. Proc Natl Acad Sci USA 100:532–537 (2003).
9.
Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, et al: Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet 43:625–633 (2006).
10.
Milunsky JM, Maher TA, Zhao G, Roberts AE, Stalker HJ, et al: TFAP2A mutations result in branchio-oculo-facial syndrome. Am J Hum Genet 82:1171–1177 (2008).
11.
Nishimura DY, Swiderski RE, Alward WL, Searby CC, Patil SR, et al: The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet 19:140–147 (1998).
12.
Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T: AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. Proc Natl Acad Sci USA 95:13714–13719 (1998).
13.
Nüsslein-Volhard CD: Zebrafish. A practical approach. (Oxford University Press, Oxford 2002).
14.
O’Brien EK, d’Alencon C, Bonde G, Li W, Schoenebeck J, et al: Transcription factor Ap-2alpha is necessary for development of embryonic melanophores, autonomic neurons and pharyngeal skeleton in zebrafish. Dev Biol 265:246–261 (2004).
15.
Rader K, Orlando RA, Lou X, Farquhar MG: Characterization of ANKRA, a novel ankyrin repeat protein that interacts with the cytoplasmic domain of megalin. J Am Soc Nephrol 11:2167–2178 (2000).
16.
Rahimov F, Marazita ML, Visel A, Cooper ME, Hitchler MJ, et al: Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet 40:1341–1347 (2008).
17.
Raveh E, Papsin BC, Forte V: Branchio-oculo-facial syndrome. Int J Pediatr Otorhinolaryngol 53:149–156 (2000).
18.
Rojas-Martinez A, Garcia-Cruz D, Medina C, Moller M, Restrepo CM, Rivera H: Tandem duplication of proximal 5q. Ann Genet 33:228–230 (1990).
19.
Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ: Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381:235–238 (1996).
20.
Stoetzel C, Riehm S, Bennouna Greene V, Pelletier V, Vigneron J, et al: Confirmation of TFAP2A gene involvement in branchio-oculo-facial syndrome (BOFS) and report of temporal bone anomalies. Am J Med Genet A 149A:2141–2146 (2009).
21.
Takahashi H, Shintani T, Sakuta H, Noda M: CBF1 controls the retinotectal topographical map along the anteroposterior axis through multiple mechanisms. Development 130:5203–5215 (2003).
22.
Takahashi H, Sakuta H, Shintani T, Noda M: Functional mode of FoxD1/CBF2 for the establishment of temporal retinal specificity in the developing chick retina. Dev Biol 331:300–310 (2009).
23.
Tekin M, Sirmaci A, Yuksel-Konuk B, Fitoz S, Sennaroglu L: A complex TFAP2A allele is associated with branchio-oculo-facial syndrome and inner ear malformation in a deaf child. Am J Med Genet A 149A:427–430 (2009).
24.
Thisse BT: Fast release clones: A high throughput expression analysis. ZFIN Direct Data Submission (http://zfin org) (2004).
25.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034 http://genomebiology.com/2002/3/7/research/0034 (2002).
26.
Wiedmann B, Sakai H, Davis TA, Wiedmann M: A protein complex required for signal-sequence-specific sorting and translocation. Nature 370:434–440 (1994).
27.
Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, et al: Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381:238–241 (1996).
28.
Zou YS, Newton S, Milunsky JM: A complex maternal rearrangement results in a pure 10.8 Mb duplication of the 5q13.1–q14.1 region in an affected son. Am J Med Genet A 152A: 498–503 (2010).
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.